These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2461561)

  • 1. cAMP-mediated phosphorylation of the low-Km cAMP phosphodiesterase markedly stimulates its catalytic activity.
    Grant PG; Mannarino AF; Colman RW
    Proc Natl Acad Sci U S A; 1988 Dec; 85(23):9071-5. PubMed ID: 2461561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylation results in activation of a cAMP phosphodiesterase in human platelets.
    Macphee CH; Reifsnyder DH; Moore TA; Lerea KM; Beavo JA
    J Biol Chem; 1988 Jul; 263(21):10353-8. PubMed ID: 2839485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of cyclic GMP-binding and cyclic AMP-specific phosphodiesterases of rat platelets by a mechanism involving cyclic AMP-dependent phosphorylation.
    Tremblay J; Lachance B; Hamet P
    J Cyclic Nucleotide Protein Phosphor Res; 1985; 10(4):397-411. PubMed ID: 2411769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intact cell and cell-free phosphorylation and concomitant activation of a low Km, cAMP phosphodiesterase found in human platelets.
    Macphee CH; Reifsnyder DH; Moore TA; Beavo JA
    J Cyclic Nucleotide Protein Phosphor Res; 1986-1987; 11(7):487-96. PubMed ID: 2831258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Model of prostaglandin-regulated cyclic AMP metabolism in intact platelets: examination of time-dependent effects on adenylate cyclase and phosphodiesterase activities.
    Ashby B
    Mol Pharmacol; 1989 Dec; 36(6):866-73. PubMed ID: 2481225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual regulation of cyclic AMP formation by thrombin in HEL cells, a leukaemic cell line with megakaryocytic properties.
    Brass LF; Woolkalis MJ
    Biochem J; 1992 Jan; 281 ( Pt 1)(Pt 1):73-80. PubMed ID: 1310010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation and regulation of the cGMP-inhibited cAMP phosphodiesterase in human erythroleukemia cells.
    Sheth SB; Brennan KJ; Biradavolu R; Colman RW
    Thromb Haemost; 1997 Jan; 77(1):155-62. PubMed ID: 9031467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombin regulates intracellular cyclic AMP concentration in human platelets through phosphorylation/activation of phosphodiesterase 3A.
    Zhang W; Colman RW
    Blood; 2007 Sep; 110(5):1475-82. PubMed ID: 17392505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for regulatory control of canine platelet phosphodiesterase.
    Boudreaux MK; Dodds WJ; Slauson DO; Catalfamo JL
    Biochem Biophys Res Commun; 1986 Oct; 140(2):589-94. PubMed ID: 3022725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imidazoquinoline derivatives: potent inhibitors of platelet cAMP phosphodiesterase which elevate cAMP levels and activate protein kinase in platelets.
    Seiler S; Gillespie E; Arnold AJ; Brassard CL; Meanwell NA; Fleming JS
    Thromb Res; 1991 Apr; 62(1-2):31-42. PubMed ID: 1649498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of overlapping but distinct cAMP and cGMP interaction sites with cyclic nucleotide phosphodiesterase 3A by site-directed mutagenesis and molecular modeling based on crystalline PDE4B.
    Zhang W; Ke H; Tretiakova AP; Jameson B; Colman RW
    Protein Sci; 2001 Aug; 10(8):1481-9. PubMed ID: 11468344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long PDE4 cAMP specific phosphodiesterases are activated by protein kinase A-mediated phosphorylation of a single serine residue in Upstream Conserved Region 1 (UCR1).
    MacKenzie SJ; Baillie GS; McPhee I; MacKenzie C; Seamons R; McSorley T; Millen J; Beard MB; van Heeke G; Houslay MD
    Br J Pharmacol; 2002 Jun; 136(3):421-33. PubMed ID: 12023945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation and characterization of bovine cardiac muscle cGMP-inhibited phosphodiesterase: a receptor for new cardiotonic drugs.
    Harrison SA; Reifsnyder DH; Gallis B; Cadd GG; Beavo JA
    Mol Pharmacol; 1986 May; 29(5):506-14. PubMed ID: 3010079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenge of human Jurkat T-cells with the adenylate cyclase activator forskolin elicits major changes in cAMP phosphodiesterase (PDE) expression by up-regulating PDE3 and inducing PDE4D1 and PDE4D2 splice variants as well as down-regulating a novel PDE4A splice variant.
    Erdogan S; Houslay MD
    Biochem J; 1997 Jan; 321 ( Pt 1)(Pt 1):165-75. PubMed ID: 9003416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of cyclic nucleotide phosphodiesterase isozymes in intact canine trachealis.
    Torphy TJ; Zhou HL; Burman M; Huang LB
    Mol Pharmacol; 1991 Mar; 39(3):376-84. PubMed ID: 1848659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-step affinity purification, partial structure and properties of human platelet cGMP inhibited cAMP phosphodiesterase.
    Degerman E; Moos M; Rascón A; Vasta V; Meacci E; Smith CJ; Lindgren S; Andersson KE; Belfrage P; Manganiello V
    Biochim Biophys Acta; 1994 Apr; 1205(2):189-98. PubMed ID: 8155697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation of beta adrenoceptors in a human monocyte cell line (U937) up-regulates cyclic AMP-specific phosphodiesterase activity.
    Torphy TJ; Zhou HL; Cieslinski LB
    J Pharmacol Exp Ther; 1992 Dec; 263(3):1195-205. PubMed ID: 1335058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormonal regulation of 3',5'-adenosine monophosphate phosphodiesterases in cultured rat granulosa cells.
    Conti M; Kasson BG; Hsueh AJ
    Endocrinology; 1984 Jun; 114(6):2361-8. PubMed ID: 6202500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective effects of phosphodiesterase inhibitors on different phosphodiesterases, adenosine 3',5'-monophosphate metabolism, and lipolysis in 3T3-L1 adipocytes.
    Elks ML; Manganiello VC
    Endocrinology; 1984 Oct; 115(4):1262-8. PubMed ID: 6207009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence that insulin and isoprenaline activate the cGMP-inhibited low-Km cAMP phosphodiesterase in rat fat cells by phosphorylation.
    Degerman E; Smith CJ; Tornqvist H; Vasta V; Belfrage P; Manganiello VC
    Proc Natl Acad Sci U S A; 1990 Jan; 87(2):533-7. PubMed ID: 2153956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.